Back

Latest Forum Topics / IX Biopharma    Last:0.33    -0.015

Post Reply

iX Biopharma Post Reply Rate topic
thankfully888 Member	24-Nov-2021 10:10        thankfully888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	THIS IS INCREDIBLE $12 million SG in upfront payment is more than the estimated $5 million SG estimated by Philips. $323 million SG in milestone and double digit royalities on a product on a market worth billions of dollars. Happy to see ix making inroads to US and China
Useful To Me  Not Useful To Me
rtan32 Member	24-Nov-2021 10:08        rtan32 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Finally what we are waiting have reward.
Useful To Me  Not Useful To Me
jack_ng Member	24-Nov-2021 09:57        jack_ng About Contact  Quote this Post!
x 0   x 0  Alert Admin	Solid Income and promising future income  https://links.sgx.com/1.0.0/corporate-announcements/X62S0S41VUNH2004/691878_Press%20Release%20-%20Wafermine%20out-licensing.pdf
Useful To Me  Not Useful To Me
rtan32 Member	23-Nov-2021 15:57        rtan32 About Contact  Quote this Post!
x 0   x 0  Alert Admin	ix normally announced their news on morning before trading hour. Not ever one time halt their trading, this time should be big news what we waiting for. Hope can huat together.
Useful To Me  Not Useful To Me
jack_ng Member	23-Nov-2021 14:12        jack_ng About Contact  Quote this Post!
x 0   x 0  Alert Admin	Fingers cross and hopefully it could be good as the share prices sudddenly shoot up with high volume and halt
Useful To Me  Not Useful To Me
thankfully888 Member	23-Nov-2021 13:59        thankfully888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Same here, been holding this for long because I think it is hugely undervalued. Unfortunately, I feel not many investors and punters understand pharmaceutical stocks and only interested in seeing profitability. Pharma stocks, fraught in uncertainty but yield the biggest ROI when successful. This reminds me of BNGO newbridge      ( Date: 23-Nov-2021 13:37) Posted: I have been holding this stock for long time.  Hope it can cheong high up..
Useful To Me  Not Useful To Me
newbridge Member	23-Nov-2021 13:37        newbridge About Contact  Quote this Post!
x 0   x 0  Alert Admin	I have been holding this stock for long time.  Hope it can cheong high up..
Useful To Me  Not Useful To Me
thankfully888 Member	23-Nov-2021 13:18        thankfully888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	If I am not wrong, trading halt news is usually news that impacts the company. With sentiment, maybe Hyphens can get pulled as well but I do not think by much. Can share why you think this piece of news can pull Hyphens as well? If this is either HK spin-off or wafermine outlicenscing, the Philips target looks very reasonable. AnthonyWoodPeck      ( Date: 23-Nov-2021 11:59) Posted: Hyphens Pharma can be pulled along too. 295-300 based out. Can watch this too
Useful To Me  Not Useful To Me
AnthonyWoodPeck Member	23-Nov-2021 11:59        AnthonyWoodPeck About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hyphens Pharma can be pulled along too. 295-300 based out. Can watch this too
Useful To Me  Not Useful To Me
thankfully888 Member	23-Nov-2021 11:15        thankfully888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Doubt they need to raise funds since they have done one round recently. Can' t think of any bad news that will hit now, there has been accumulation at 0.23 to 0.235. It should be good news incoming.
Useful To Me  Not Useful To Me
jack_ng Member	23-Nov-2021 11:07        jack_ng About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hoping for some good news as the prices raise 10% and halted  oceanblue      ( Date: 23-Nov-2021 09:36) Posted: Any news? Volume quite high this morning.
Useful To Me  Not Useful To Me
oceanblue Veteran	23-Nov-2021 09:36        oceanblue About Contact  Quote this Post!
x 0   x 0  Alert Admin	Any news? Volume quite high this morning.
Useful To Me  Not Useful To Me
ahberngh Elite	27-Oct-2021 10:18        ahberngh About Contact  Quote this Post!
x 0   x 0  Alert Admin	Yes, True Niagen is a hot product, I have bought from Amazon before (cheaper than buying from Watson ). Made its manufacturer a lot of money. IX product should have advantage with its sublingual technology, ingested under the tongue faster and more effective compared to swallowing. rtan32      ( Date: 27-Oct-2021 07:59) Posted: NAD+ should be game charging product, the same product selling at WATSON are TRU NIAGEN and sold about 1.3 mil units since 2017 in HONG KONG.
Useful To Me  Not Useful To Me
rtan32 Member	27-Oct-2021 07:59        rtan32 About Contact  Quote this Post!
x 0   x 0  Alert Admin	NAD+ should be game charging product, the same product selling at WATSON are TRU NIAGEN and sold about 1.3 mil units since 2017 in HONG KONG.
Useful To Me  Not Useful To Me
jack_ng Member	26-Oct-2021 17:42        jack_ng About Contact  Quote this Post!
x 0   x 0  Alert Admin	Al the news are great but It will be greater if the news announced in 2nd June 2021 that the production had increase capacity and the company is able generate more sales and show some profit instead of reduced loss    If not we may have to wait longer for the stock price to reach its target look@bright      ( Date: 26-Oct-2021 10:12) Posted: LOL spursfan      ( Date: 26-Oct-2021 08:12) Posted: NEWS RELEASE iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product ✓ 1 st sublingual NAD+ wafer to deliver pure NAD+, instead of its precursors ✓ 3 rd product in its popular NAD+ line-up and 3 rd sublingual Entity Health product Singapore, 26 October 2021 &ndash Specialty pharmaceutical company iX Biopharma Ltd (&ldquo iX Biopharma&rdquo or, the &ldquo Group&rdquo ) has rolled out its game-changing SL-NAD+TM, a sublingual wafer containing pure nicotinamide adenine dinucleotide (NAD+), under its Entity Health nutraceutical brand. For the first time ever, pure and intact NAD+, also known as the molecule of youth, can be delivered directly into the bloodstream through a convenient sublingual freeze-dried wafer, without the need for invasive intravenous drips or injections. The Company leveraged its patented WaferiX sublingual drug delivery technology and proprietary freeze-drying manufacturing process to stabilise and preserve the integrity of the otherwise volatile NAD+ molecule. Dr Janakan Krishnarajah, Chief Operating Officer of iX Biopharma, said, &ldquo SL-NAD+ is differentiated from other nicotinamide supplements in the market in that it does not use precursors of NAD+ which need to be converted into NAD+ in the body. SL-NAD+ is the result of the successful incorporation of pure NAD+ into our WaferiX wafers, which is able to maintain the integrity of the active ingredient and disintegrate rapidly under the tongue for maximum absorption.&rdquo   Found in every human cell, NAD+ is a coenzyme that plays a critical role in many of the human body&rsquo s fundamental processes, such as converting nutrients into energy and maintaining cellular health and longevity. The loss of NAD+ levels with age is known to result in reduced energy, increased inflammation, and reduced cellular repair and organ function. These contribute to symptoms of aging such as fatigue, memory decline, joint and muscle pain, compromised immune function, increase susceptibility to infections and diseases. Replenishing the body&rsquo s NAD+ levels thus helps to combat aging, support energy generation and activate sirtuins, which are proteins associated with delaying the aging process. SL-NAD+ is the third sublingual product in the Entity Health portfolio, with the other two being LumeniX, a sublingual glutathione and WafeRest, a sublingual melatonin. SL-NAD+ is available on the www.entity-health.com web store from 25 October 2021, and through its ecommerce channels in China, including Tmall Global and JD Worldwide, from November 2021. https://links.sgx.com/1.0.0/corporate-announcements/NNG0VMMHIDLF7D9Z/688029_Press%20Release%20-%20iX%20Biopharma%20Expands%20Nutraceutical%20Portfolio%20with%20Sublingual%20NAD%20Product.pdf
Useful To Me  Not Useful To Me
look@bright Elite	26-Oct-2021 10:12        look@bright About Contact  Quote this Post!
x 0   x 0  Alert Admin	LOL spursfan      ( Date: 26-Oct-2021 08:12) Posted: NEWS RELEASE iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product ✓ 1 st sublingual NAD+ wafer to deliver pure NAD+, instead of its precursors ✓ 3 rd product in its popular NAD+ line-up and 3 rd sublingual Entity Health product Singapore, 26 October 2021 &ndash Specialty pharmaceutical company iX Biopharma Ltd (&ldquo iX Biopharma&rdquo or, the &ldquo Group&rdquo ) has rolled out its game-changing SL-NAD+TM, a sublingual wafer containing pure nicotinamide adenine dinucleotide (NAD+), under its Entity Health nutraceutical brand. For the first time ever, pure and intact NAD+, also known as the molecule of youth, can be delivered directly into the bloodstream through a convenient sublingual freeze-dried wafer, without the need for invasive intravenous drips or injections. The Company leveraged its patented WaferiX sublingual drug delivery technology and proprietary freeze-drying manufacturing process to stabilise and preserve the integrity of the otherwise volatile NAD+ molecule. Dr Janakan Krishnarajah, Chief Operating Officer of iX Biopharma, said, &ldquo SL-NAD+ is differentiated from other nicotinamide supplements in the market in that it does not use precursors of NAD+ which need to be converted into NAD+ in the body. SL-NAD+ is the result of the successful incorporation of pure NAD+ into our WaferiX wafers, which is able to maintain the integrity of the active ingredient and disintegrate rapidly under the tongue for maximum absorption.&rdquo   Found in every human cell, NAD+ is a coenzyme that plays a critical role in many of the human body&rsquo s fundamental processes, such as converting nutrients into energy and maintaining cellular health and longevity. The loss of NAD+ levels with age is known to result in reduced energy, increased inflammation, and reduced cellular repair and organ function. These contribute to symptoms of aging such as fatigue, memory decline, joint and muscle pain, compromised immune function, increase susceptibility to infections and diseases. Replenishing the body&rsquo s NAD+ levels thus helps to combat aging, support energy generation and activate sirtuins, which are proteins associated with delaying the aging process. SL-NAD+ is the third sublingual product in the Entity Health portfolio, with the other two being LumeniX, a sublingual glutathione and WafeRest, a sublingual melatonin. SL-NAD+ is available on the www.entity-health.com web store from 25 October 2021, and through its ecommerce channels in China, including Tmall Global and JD Worldwide, from November 2021. https://links.sgx.com/1.0.0/corporate-announcements/NNG0VMMHIDLF7D9Z/688029_Press%20Release%20-%20iX%20Biopharma%20Expands%20Nutraceutical%20Portfolio%20with%20Sublingual%20NAD%20Product.pdf
Useful To Me  Not Useful To Me
Fluffyclouds Master	26-Oct-2021 08:40        Fluffyclouds About Contact  Quote this Post! Style: Fundamental   Mood:
x 0   x 0  Alert Admin	Finally, swee!  spursfan      ( Date: 26-Oct-2021 08:12) Posted: NEWS RELEASE iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product ✓ 1 st sublingual NAD+ wafer to deliver pure NAD+, instead of its precursors ✓ 3 rd product in its popular NAD+ line-up and 3 rd sublingual Entity Health product Singapore, 26 October 2021 &ndash Specialty pharmaceutical company iX Biopharma Ltd (&ldquo iX Biopharma&rdquo or, the &ldquo Group&rdquo ) has rolled out its game-changing SL-NAD+TM, a sublingual wafer containing pure nicotinamide adenine dinucleotide (NAD+), under its Entity Health nutraceutical brand. For the first time ever, pure and intact NAD+, also known as the molecule of youth, can be delivered directly into the bloodstream through a convenient sublingual freeze-dried wafer, without the need for invasive intravenous drips or injections. The Company leveraged its patented WaferiX sublingual drug delivery technology and proprietary freeze-drying manufacturing process to stabilise and preserve the integrity of the otherwise volatile NAD+ molecule. Dr Janakan Krishnarajah, Chief Operating Officer of iX Biopharma, said, &ldquo SL-NAD+ is differentiated from other nicotinamide supplements in the market in that it does not use precursors of NAD+ which need to be converted into NAD+ in the body. SL-NAD+ is the result of the successful incorporation of pure NAD+ into our WaferiX wafers, which is able to maintain the integrity of the active ingredient and disintegrate rapidly under the tongue for maximum absorption.&rdquo   Found in every human cell, NAD+ is a coenzyme that plays a critical role in many of the human body&rsquo s fundamental processes, such as converting nutrients into energy and maintaining cellular health and longevity. The loss of NAD+ levels with age is known to result in reduced energy, increased inflammation, and reduced cellular repair and organ function. These contribute to symptoms of aging such as fatigue, memory decline, joint and muscle pain, compromised immune function, increase susceptibility to infections and diseases. Replenishing the body&rsquo s NAD+ levels thus helps to combat aging, support energy generation and activate sirtuins, which are proteins associated with delaying the aging process. SL-NAD+ is the third sublingual product in the Entity Health portfolio, with the other two being LumeniX, a sublingual glutathione and WafeRest, a sublingual melatonin. SL-NAD+ is available on the www.entity-health.com web store from 25 October 2021, and through its ecommerce channels in China, including Tmall Global and JD Worldwide, from November 2021. https://links.sgx.com/1.0.0/corporate-announcements/NNG0VMMHIDLF7D9Z/688029_Press%20Release%20-%20iX%20Biopharma%20Expands%20Nutraceutical%20Portfolio%20with%20Sublingual%20NAD%20Product.pdf
Useful To Me  Not Useful To Me
spursfan Supreme	26-Oct-2021 08:12        spursfan About Contact  Quote this Post!
x 0   x 0  Alert Admin	NEWS RELEASE iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product ✓ 1 st sublingual NAD+ wafer to deliver pure NAD+, instead of its precursors ✓ 3 rd product in its popular NAD+ line-up and 3 rd sublingual Entity Health product Singapore, 26 October 2021 &ndash Specialty pharmaceutical company iX Biopharma Ltd (&ldquo iX Biopharma&rdquo or, the &ldquo Group&rdquo ) has rolled out its game-changing SL-NAD+TM, a sublingual wafer containing pure nicotinamide adenine dinucleotide (NAD+), under its Entity Health nutraceutical brand. For the first time ever, pure and intact NAD+, also known as the molecule of youth, can be delivered directly into the bloodstream through a convenient sublingual freeze-dried wafer, without the need for invasive intravenous drips or injections. The Company leveraged its patented WaferiX sublingual drug delivery technology and proprietary freeze-drying manufacturing process to stabilise and preserve the integrity of the otherwise volatile NAD+ molecule. Dr Janakan Krishnarajah, Chief Operating Officer of iX Biopharma, said, &ldquo SL-NAD+ is differentiated from other nicotinamide supplements in the market in that it does not use precursors of NAD+ which need to be converted into NAD+ in the body. SL-NAD+ is the result of the successful incorporation of pure NAD+ into our WaferiX wafers, which is able to maintain the integrity of the active ingredient and disintegrate rapidly under the tongue for maximum absorption.&rdquo   Found in every human cell, NAD+ is a coenzyme that plays a critical role in many of the human body&rsquo s fundamental processes, such as converting nutrients into energy and maintaining cellular health and longevity. The loss of NAD+ levels with age is known to result in reduced energy, increased inflammation, and reduced cellular repair and organ function. These contribute to symptoms of aging such as fatigue, memory decline, joint and muscle pain, compromised immune function, increase susceptibility to infections and diseases. Replenishing the body&rsquo s NAD+ levels thus helps to combat aging, support energy generation and activate sirtuins, which are proteins associated with delaying the aging process. SL-NAD+ is the third sublingual product in the Entity Health portfolio, with the other two being LumeniX, a sublingual glutathione and WafeRest, a sublingual melatonin. SL-NAD+ is available on the www.entity-health.com web store from 25 October 2021, and through its ecommerce channels in China, including Tmall Global and JD Worldwide, from November 2021. https://links.sgx.com/1.0.0/corporate-announcements/NNG0VMMHIDLF7D9Z/688029_Press%20Release%20-%20iX%20Biopharma%20Expands%20Nutraceutical%20Portfolio%20with%20Sublingual%20NAD%20Product.pdf
Useful To Me  Not Useful To Me
rtan32 Member	02-Oct-2021 18:32        rtan32 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Just visited IX company new web page, more details and clear. Hope the agreement sign with CHINA RESOURCE and the new web page is the beginning and the share price start moving uptrend.
Useful To Me  Not Useful To Me
SmallSmall Supreme	01-Oct-2021 20:50        SmallSmall About Contact  Quote this Post!
x 0   x 0  Alert Admin	That is why I say the company should provide free sample for investors to try for them to gauge the product effectiveness. China is a big market. If the product is good and if they can market it well I am sure the company' s share price will " stand up" for a long time. jack_ng      ( Date: 01-Oct-2021 10:20) Posted: No Amount of enhancer will be as strong enough unless it start showing some profit to really make it solid and for it to go UP (prices) SmallSmall      ( Date: 30-Sep-2021 19:44) Posted: Sigh. Viagra also cannot help the company (price) to stay firm
Useful To Me  Not Useful To Me

                                                         First   < Newer   1841-1860 of 5075   Older>   Last